Combination Assay and Software product for HLA genotyping by NGS for use on Illumina® sequencers.
Dual-algorithm HLA genotyping software for NGS data that delivers the most accurate HLA genotyping available.
Advanced HLA genotyping software for genetics / genomics researchers to interpret any NGS data. (beta version)
What we do
Omixon is a molecular diagnostics company dedicated to transitioning the HLA community to Next Generation Sequencing (NGS) technologies with its best-in-class assays and software.
Highest level of leadership
Our key opinion leaders and major collaborators in the HLA community have provided the highest level of leadership for several decades and helped pave the way for the adoption of NGS.
Omixon has evolved into a global molecular diagnostics company that is currently focused on driving the adoption of NGS in the clinic with Holotype HLA, the world’s leading NGS-based HLA genotyping Assay and Software product.
NGS FOR HLA EXPERTS
Our flagship product Holotype HLA was designed in a clinical lab at the Children’s Hospital of Philadelphia by Professor Dimitri Monos. It is a combination NGS Assay and Software product for use on Illumina® sequencers.
Believe the data:
- 15+ HLA labs in clinical routine worldwide
- 75+ HLA labs trained onsite worldwide
- 2500+ samples in worldwide Early Access Program
- 2500+ routine clinical samples analyzed at CHOP
- 253 samples for ASHI validation study at CHOP
- 200 samples, 3 lots for CE Mark Performance Study